GREATER CHINA Results China Construction Bank (939 HK/HOLD/HK$6.79/Target: HK$7.00): 1Q25: Earnings miss due to weaker NIM and fee income; tariff risk is limited. Downgrade to HOLD. China Longyuan Power (916 HK/HOLD/HK$6.10/Target: HK$6.60): 1Q25: In line; cautious outlook amid rising curtailment rates and upcoming policy shift. China Merchants Bank (3968 HK/BUY/HK$44.50/Target: HK$49.00): 1Q25: Earnings down 2.1% yoy on weaker trading gains. Estun Automation (002747 CH/SELL/Rmb19.17/Target: Rmb...
GREATER CHINA Strategy Small-Mid Cap Biweekly: Pet food exports on track for recovery; beneficiary: Yantai China Pet Food. Results BYD Company (1211 HK/BUY/HK$246.20/Target: HK$630.00): 3Q23: Earnings up 82% yoy and 53% qoq, in line. Maintain BUY. Target price: HK$630.00. China Construction Bank (939 HK/BUY/HK$4.48/Target: HK$6.00): 3Q23: Results in line; earnings up 2.6% on lower credit costs. China Merchants Bank Co. (3968 HK/BUY/HK$30.30/Target: HK$45.00): 3Q23: Results miss; longer wait need...
Chinese banks recorded a modest 2.7% earnings growth, primarily attributed to rising trading gains and reduced provisions, which counterbalanced the adverse effects of NIM compression and sluggish fee income. The sector's valuation has suffered in recent years due to market concerns on NIM compression and asset quality. At this point, the sector is trading at a fairly balanced valuation, with the attractive 7% yield offsetting the impact of NIM compression. Maintain MARKET WEIGHT.
GREATER CHINA Results AAC Technologies (2018 HK/HOLD/ HK$15.56/ Target: HK$14.50): 1H23: Margins deteriorated further; better visibility of recovery in 2H23. AIA Group (1299 HK/BUY/ HK$69.95/Target: HK$95.00): 1H23: VONB in line; margin slumps a concern. Aier Eye Hospital Group (300015 CH/BUY/Rmb18.02/Target: Rmb26.00): 1H23: Satisfactory results; strong demand to further boost revenue growth. China Construction Bank (939 HK/BUY/HK$4.11/Target: HK$6.30): 1H23: Earnings continue to thrive despite...
GREATER CHINA Sector Aviation: Airlines: Three major airlines still loss-making in 2Q23. Maintain UNDERWEIGHT with Air China (753HK/BUY/Target: HK$6.32) as our top pick. Property: Latest comments by PBOC official Zou Lan point to further policy easing. Update China Construction Bank (939 HK/BUY/HK$4.39/Target: HK$6.30): 1H23 results preview: NIM dilution is expected to ease; recovery of non-interest income to support earnings growth. Maintain BUY. JD.com (9618 HK/BUY/HK$150.70/Target: HK$216.00)...
CCB’s net profit grew 2.0% yoy, mainly dragged by the decline in interest income caused by multiple LPR cuts. Despite a significant exposure in the property segment, management guided that CCB’s exposure in the real estate industry is controllable and expects NIM to stabilise in the next few quarters. Maintain BUY with a target price of HK$6.06
KEY HIGHLIGHTS Economics PMI Points to weak employment outlook. Sector Aviation Airlines: 1Q23 narrowing losses broadly in line with expectations. Maintain UNDERWEIGHT. Results Baoshan Iron & Steel (600019 CH/BUY/Rmb6.44/Target: Rmb7.10) 2022/1Q23: In line; speeding up M&A. China Construction Bank (939 HK/BUY/HK$5.25/Target: HK$6.06) 1Q23: Results in line; NIM to stabilise in next few quarters. China Merchants Bank (3968 HK/BUY/HK$37.65/Target: HK$58.00) 1Q23: Results in line; cautiously op...
CCB’s attributable net profit grew 7.1% yoy, mainly due to a notable decline in noninterest income. Property risk remains manageable, as shown by the 0.04ppt decrease in the NPL ratio. While NIM compression continues to impact industry-wide earnings, increased demand for lending as China’s economy recovers should partially offset the negative deviation. Maintain BUY with target price reduced to HK$6.06.
KEY HIGHLIGHTS Results China Construction Bank (939 HK/BUY/HK$5.07/Target: HK$6.06) 2022: Results in line; expect NIM compression to continue in 2023. China Mengniu Dairy (2319 HK/BUY/HK$32.60/Target: HK$39.30) 2022: Results below expectations; upbeat on future margin expansion. China Shineway Pharmaceutical (2877 HK/BUY/HK$7.26/Target: HK$10.50) 2022: Earnings growth beats expectations; TCM granule business continues to drive growth. Ganfeng Lithium (1772 HK/SELL/HK$49.45/Target: HK$35.00) ...
GREATER CHINA Results China Construction Bank (939 HK/BUY/HK$5.07/Target: HK$6.06): 2022: Results in line; expect NIM compression to continue in 2023. China Mengniu Dairy (2319 HK/BUY/HK$32.60/Target: HK$39.30): 2022: Results below expectations; upbeat on future margin expansion. Ganfeng Lithium (1772 HK/SELL/HK$49.45/Target: HK$35.00): 4Q22: Earnings missed our estimates; maintain SELL. Guangzhou Automobile Group (2238 HK/SELL/HK$4.99/Target: HK$4.00): 4Q22: Results grossly missed estimates. Ma...
China's bank bond market investments do not have overseas AT1 holdings, limiting the potential contagion risk to the Chinese banking system. China’s AT1 bonds differ from overseas AT1 bonds mainly on their: a) write-down clauses with specific trigger conditions, while foreign AT1 bonds can have principal write-downs; b) dividend suspension mechanism; and c) higher probability of redemption. Maintain MARKET WEIGHT. Our top pick is CMB (3968 HK).
CCB’s delivered in line 3Q22 results, with net profit improving 8.61% yoy, lifted by better-than-expected net interest income, despite NIM compression and a lacklustre non-interest income. While management expects that 4Q22’s NIM will sustain its downward momentum, we expect CCB to deliver solid earnings recovery in 4Q22 with its stable asset quality which offers attractive share price upside on its bargain valuations. Maintain BUY. Target price: HK$5.94.
KEY HIGHLIGHTS Economics PMI Loses momentum. Results China Construction Bank (939 HK/BUY/HK$4.17/Target: HK$5.94) 3Q22: Results in line; steep decline in non-interest income. China Merchants Bank (3968 HK/BUY/HK$25.80/Target: HK$41.43) 3Q22: Results in line. Resilient earnings despite NIM compression. Ganfeng Lithium (1772 HK/SELL/HK$53.10/Target: HK$37.00) 3Q22: Earnings line with estimates, margins squeezed qoq. Maintain SELL. Target price: HK$37.00. Ningbo Xusheng Group (603305 CH/BUY/Rm...
GREATER CHINA Economics PMI: Loses momentum. Results China Construction Bank (939 HK/BUY/HK$4.17/Target: HK$5.94): 3Q22: Results in line; steep decline in non-interest income. China Merchants Bank (3968 HK/BUY/HK$25.80/Target: HK$41.43): 3Q22: Results in line. Resilient earnings despite NIM compression. Ganfeng Lithium (1772 HK/SELL/HK$53.10/Target: HK$37.00): 3Q22: Earnings line with estimates, margins squeezed qoq. Maintain SELL. Target price: HK$37.00. Ningbo Xusheng Group (603305 CH/BUY/Rmb3...
GREATER CHINA Economics PMI: Manufacturing PMI remains below 50%, but there are pockets of strength. Results Baoshan Iron & Steel (600019 CH/BUY/Rmb5.33/Target: Rmb6.50): 1H22: Below expectations; surge in coking coal prices weigh on margins. China Construction Bank (939 HK/BUY/HK$4.87/Target: HK$6.38): 1H22: Results in line. China Resources Land (1109 HK/BUY/HK$32.25 /Target: HK$43.60): 1H22: Core net profit in line with expectations. Estun Automation (002747 CH/HOLD/Rmb18.90/Target: Rmb21.50):...
KEY HIGHLIGHTS Economics PMI Manufacturing PMI remains below 50%, but there are pockets of strength. Results Baoshan Iron & Steel (600019 CH/BUY/Rmb5.33/Target: Rmb6.50) 1H22: Below expectations; surge in coking coal prices weigh on margins. China Construction Bank (939 HK/BUY/HK$4.87/Target: HK$6.38) 1H22: Results in line. China Resources Land (1109 HK/BUY/HK$32.25 /Target: HK$43.60) 1H22: Core net profit in line with expectations. Estun Automation (002747 CH/HOLD/Rmb18.90/Target: Rmb21.50...
On 22 Aug 22, the PBOC reduced the one-year LPR by 5bp from 3.70% to 3.65% and five-year LPR by 15bp from 4.45% to 4.30%. The rate cuts were in line with market expectations and we expect more rate cuts to come to cushion growth in 2022. The impact on banks is minimal and the concern over asset quality will persist. Maintain MARKET WEIGHT. Top picks are CMB (3968 HK) and CCB (939 HK) with a target price of HK$52.87 and HK$6.38 respectively.
Buyers of over 150 property projects have collectively refused to make mortgage payments for unfinished, pre-sold units unless construction resumes. We estimate aggregate GFA of projects with serious delayed delivery at 147m-205m sqm. While we expect the unfolding boycott to likely negatively impact buyers’ sentiment and further tighten developers’ financing, the impact on China banks remains manageable and should alleviate market concerns. Maintain MARKET WEIGHT on both sectors.
TSF improved in May 22 but medium- and long-term loans remained weak. We expect to see a recovery in Jun 22 on the back of the economic reopening. Overall credit data remains weak and could pose challenges to banks’ 2Q22 revenue growth. Hence, we revised our forecast due to the weaker loan demand. Top picks are CMB (3968 HK) and CCB (939 HK), with target prices lowered to HK$68.40 and HK$7.75 respectively.
The 1Q22 China Monetary Policy Report indicated that most of the banks in China have lowered their interest rates. The new weighted average deposit rate of China financial institutions in end-Apr 22 was 2.37%, decreasing 10bp from the previous week. Weak trade figures raise the risk of China's GDP shrinking. We expect more rate cuts to be taken to bolster the economy. Top picks are CMB (3968 HK) and CCB (939 HK) with a target price of HK$82.9 and HK$8.05 respectively.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.